Whitehawk Therapeutics (WHWK) Interest & Investment Income (2020 - 2026)
Whitehawk Therapeutics' (WHWK) quarterly Interest & Investment Income came in at -$135000.0 in Q1 2026, down 800.0% year-on-year from $19285.7 in Q1 2025, and up 97.01% on a QoQ basis from -$4.5 million in Q4 2025.
Whitehawk Therapeutics (WHWK) Interest & Investment Income (2020 - 2026) Analysis & Trends
Whitehawk Therapeutics (WHWK) has 7 years of Interest & Investment Income data on file, last reported at -$135000.0 in Q1 2026.
- On a quarterly basis, Interest & Investment Income fell 800.0% year-over-year to -$135000.0 in Q1 2026; TTM through Mar 2026 was -$2.8 million, a 158.37% decrease from a year earlier, with the FY2025 full-year figure at $104000.0, down 97.35% from the prior year.
- Interest & Investment Income for Q1 2026 stood at -$135000.0, up from -$4.5 million in the prior quarter.
- Over the last five years, Interest & Investment Income for WHWK reached as high as $3.9 million in Q4 2024 and fell as low as -$4.5 million in Q4 2025.
- Historically, Interest & Investment Income has averaged $632764.7 across 5 years, with a median of $620000.0 in 2022.
- Across the five-year window, Interest & Investment Income jumped 15700.0% in 2022 and sank 800.0% in 2026, its largest moves.
- Year by year, Interest & Investment Income stood at $1.6 million in 2022, then retreated by 6.66% to $1.5 million in 2023, then jumped by 160.87% to $3.9 million in 2024, then tumbled by 215.41% to -$4.5 million in 2025, then soared by 97.01% to -$135000.0 in 2026.
- Per Business Quant data, the three most recent Interest & Investment Income figures were -$135000.0 in Q1 2026, -$4.5 million in Q4 2025, and $1.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 27.66 Mn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 114.80 Mn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | -65.80 Mn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 48.00 Mn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 19.51 Mn |
| 10 | Whitehawk Therapeutics | 256.87 Mn | 45.62 Mn | - | -135,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -135,000.00 |
| Dec 31, 2025 | -4.52 Mn |
| Sep 30, 2025 | 1.85 Mn |
| Jun 30, 2025 | 8,000.00 |
| Mar 31, 2025 | -15,000.00 |
| Dec 31, 2024 | 3.91 Mn |
| Sep 30, 2024 | 906,000.00 |
| Jun 30, 2024 | -19,000.00 |
| Mar 31, 2024 | -35,000.00 |
| Dec 31, 2023 | 1.50 Mn |
| Sep 30, 2023 | 1.61 Mn |
| Jun 30, 2023 | 1.64 Mn |
| Mar 31, 2023 | 1.66 Mn |
| Dec 31, 2022 | 1.61 Mn |
| Sep 30, 2022 | 620,000.00 |
| Jun 30, 2022 | 158,000.00 |
| Mar 31, 2022 | 15,000.00 |
| Dec 31, 2021 | 12,000.00 |
| Jun 30, 2021 | 1,000.00 |
| Sep 30, 2020 | 1,000.00 |